FDA Inspection
New York Blood Center, Inc.New York Blood Center, Inc. – FDA Inspection, Jun 23, 2026
Record Details
This FDA Inspection record concerns New York Blood Center, Inc., with an inspection on June 23, 2026, issued by the New York District Office, covering biologics.
View Company Profile
ID · a435ca70-f990-4a17-851b-842569777d9e
Inspection Facts
- Inspection number
- 1323326
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
- 21 CFR 606.60(a)Maintain and clean equipment
Full citation text and observation details available on the Dashboard.
Other FDA inspections of New York Blood Center, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| February 3, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 6, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 6, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 8, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 14, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for New York Blood Center, Inc.
- FDA Inspection 1196752 - 2023-02-03
- FDA Inspection 1064470 - 2018-08-06
- FDA Inspection 972369 - 2016-06-06
- FDA Inspection 891886 - 2014-08-08
- FDA Inspection 798581 - 2012-09-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.